The Trump administration is launching an effort aimed at bringing clinical trials back to the United States, after years of more trials moving overseas, according to a June 22 announcement from the Department of Health and Human Services (HHS).
HHS and some of its divisions, such as the Food and Drug Administration, are involved in the new effort, dubbed Operation TrailBlazer.
One of the steps is an FDA solicitation of public comments on a proposal for a pilot program that would shorten the period of time from identification of a drug to Phase 1 clinical trials.
Another is outreach by the National Institutes of Health for tips on how it can intervene in trials to make sure they are successfully completed….